These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2138116)

  • 1. The heart in hypertension and arrhythmias.
    Widimský J; Cífková R
    Herz; 1990 Feb; 15(1):49-53. PubMed ID: 2138116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy.
    McLenachan JM; Henderson E; Morris KI; Dargie HJ
    N Engl J Med; 1987 Sep; 317(13):787-92. PubMed ID: 2957590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive diagnosis of ventricular arrhythmias by means of ambulatory-ECG monitoring.
    Candinas RA; Podrid PJ
    Herz; 1990 Feb; 15(1):1-10. PubMed ID: 2179087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of cardiac risk in hypertensive patients with left heart hypertrophy].
    Schulte KL; Meyer-Sabellek W; Liederwald K; Eisenhut C; Distler A; Gotzen R
    Z Kardiol; 1991; 80 Suppl 1():37-40. PubMed ID: 1827230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension.
    Papademetriou V; Burris JF; Notargiacomo A; Fletcher RD; Freis ED
    Arch Intern Med; 1988 Jun; 148(6):1272-6. PubMed ID: 2454086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy, arterial hypertension and sudden death.
    Messerli FH
    J Hypertens Suppl; 1990 Dec; 8(7):S181-6. PubMed ID: 2151334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy and antihypertensive therapy.
    Graettinger WF; Weber MA
    Am Fam Physician; 1992 Aug; 46(2):483-91. PubMed ID: 1386180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ventricular arrhythmia in patients with hypertension and left ventricular hypertrophy].
    Sami MH
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():59-62. PubMed ID: 2150475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular arrhythmias in hypertension: in which patients do they occur?
    Mayet J; Shahi M; Poulter NR; Sever PS; Thom SA; Foale RA
    J Hypertens; 1995 Feb; 13(2):269-76. PubMed ID: 7615959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification of patients with complex ventricular arrhythmias. Value of ambulatory electrocardiographic recording, programmed electrical stimulation and the signal-averaged electrocardiogram.
    el-Sherif N; Turitto G; Fontaine JM
    Herz; 1988 Jun; 13(3):204-14. PubMed ID: 2456972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heart effect of arterial hypertension. Heart hypertrophy as a risk factor. Study technics (electrocardiogram, echocardiography, exercise test and Holter].
    Aguilera Saldaña MA; García Moreno LM; Rodríguez Padial L; Navarro Lima A; Sánchez Domínguez J
    Rev Esp Cardiol; 1990; 43 Suppl 1():54-64. PubMed ID: 2139976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of left ventricular hypertrophy: a desirable therapeutic goal?
    Schmieder RE; Messerli FH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S16-22. PubMed ID: 1707110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
    Li Z; Dahlöf B; Okin PM; Kjeldsen SE; Wachtell K; Ibsen H; Nieminen MS; Jern S; Devereux RB
    J Hypertens; 2008 Jun; 26(6):1244-9. PubMed ID: 18475164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsustained Ventricular Tachycardia as a Predictor of Cardiovascular Events in Black Men With Hypertensive Left Ventricular Hypertrophy.
    Greenberg MD; Papademetriou V; Narayan P; Kokkinos P
    J Clin Hypertens (Greenwich); 2000 Jan; 2(1):14-19. PubMed ID: 11416620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Left ventricular hypertrophy and arrhythmia. An aspect of hypertensive cardiomyopathy].
    Clémenty J; Dulhoste MN; Coste P; Gil A
    Arch Mal Coeur Vaiss; 1991 Sep; 84 Spec No 3():111-5. PubMed ID: 1835364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias].
    Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH
    Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
    Saadeh AM; Jones JV
    J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.